Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma
Neuroblastoma (NB) is the most common extracranial solid tumor in children, accounting for about 8% of childhood cancers. Despite aggressive treatment, patients suffering from high-risk NB have very poor 5-year overall survival rate, due to relapsed and/or treatment-resistant tumors. A further incre...
Main Authors: | Fabio ePastorino, Chiara eBrignole, Monica eLoi, Daniela eDi Paolo, Annarita eDi Fiore, Patrizia ePerri, Gabriella ePagnan, Mirco ePonzoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00190/full |
Similar Items
-
Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions
by: Xianqiang Li, et al.
Published: (2021-07-01) -
Targeting to brain tumor: Nanocarrier-based drug delivery platforms, opportunities, and challenges
by: Ladi Alik Kumar, et al.
Published: (2021-01-01) -
Exosomes as Actively Targeted Nanocarriers for Cancer Therapy
by: Wang Y, et al.
Published: (2020-06-01) -
Epithelial and Mesenchymal Tumor Compartments Exhibit In Vivo Complementary Patterns of Vascular Perfusion and Glucose Metabolism
by: Mirco Galiè, et al.
Published: (2007-11-01) -
Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy
by: Benedicte F. Jordan, et al.
Published: (2012-05-01)